Edition:
United Kingdom

Union Medical Healthcare Ltd (2138.HK)

2138.HK on Hong Kong Stock

5.52HKD
25 Jun 2019
Change (% chg)

HK$0.05 (+0.91%)
Prev Close
HK$5.47
Open
HK$5.50
Day's High
HK$5.53
Day's Low
HK$5.39
Volume
398,001
Avg. Vol
1,240,185
52-wk High
HK$6.35
52-wk Low
HK$3.53

Summary

Name Age Since Current Position

Chi Fai Tang

37 2015 Executive Chairman of the Board, Chief Executive Officer

Gabriel Lee

37 2015 Chief Operating Officer, Executive Director

Yeung Cheng

44 2015 General Manager - Medical Operations

Chun Pong Siu

38 2017 Company Secretary

Kun Shing Ben Luk

36 2018 Non-Executive Director

Guowei Wang

57 2018 Non-Executive Director

Chi Hang Lam

38 2017 Non-Executive Independent Director

Andrew Look

51 2016 Non-Executive Independent Director

Ching Nam Ma

63 2016 Non-Executive Independent Director

Biographies

Name Description

Chi Fai Tang

Mr. Tang Chi Fai is Executive Chairman of the Board, Chief Executive Officer of the company. He is the Founder of our Group. He founded our Group on 23 November 2005 and was appointed as our chairman, executive Director and chief executive officer on 4 November 2015. He is responsible for the overall management and strategic planning and development of our Group. Mr. Tang has more than 13 years of experience in the aesthetic medical and beauty industries. Prior to joining our Group, from 2001 to 2005, Mr. Tang worked at Lionfaith Limited, a company engaged in public relations in Hong Kong, as a sales director primarily responsible for sales management. In 2004, Mr. Tang worked as a sales director at Nutriplus (Asia) Limited, a company engaged in direct sales of branded beauty products in Hong Kong, and a wholly-owned subsidiary of Easy Repay Finance & Investment Limited (formerly known as B.A.L. Holdings Limited) (Stock Code: 8079), listed on the Growth Enterprise Market of the Stock Exchange, which was engaged in the business of beauty and weight management in Hong Kong. During that period, he was primarily responsible for the initial establishment and business development of four beauty centres, the development of marketing strategies and maintenance of sales channels. From 2002 to 2003, Mr. Tang worked at Sau San Tong), a company later listed on the Growth Enterprise Market of the Stock Exchange (Stock Code: 8200), which provides slimming and beauty products and services in Hong Kong. He was primarily responsible for sales management. In addition, Mr. Tang also invests in businesses other than those providing aesthetic medical and beauty service businesses, such as leasing of warehouse spaces, insurance brokerage, medical equipment maintenance and repair, and supply of cosmetic products, medical devices, consumables and equipment. Please see “Relationship with Controlling Shareholders—Excluded Inter From September 1998 to May 2001.

Gabriel Lee

Mr. Lee Gabriel is Chief Operating Officer, Executive Director of the company. He is responsible for the management of day-to-day operations for our Group. Mr. Lee has over 14 years of experience in business management. Prior to joining our Group, from July 2001 to April 2014, Mr. Lee worked at Cathay Pacific Airways Limited (“Cathay Pacific”), an international airline listed on the Main Board of the Stock Exchange (Stock Code: 293). He joined Cathay Pacific as a management trainee from July 2001 to June 2004 and subsequently served in various managerial positions, including more recently, as manager of cargo hub operations from January 2014 to April 2014 to manage the cargo operations of the airline in the Hong Kong International Airport, manager of planning and performance for the Hong Kong International Airport from August 2011 to December 2013 to oversee airport operations of the airline at the Hong Kong International Airport and manager of cargo operations of the airline from July 2009 to March 2010 to supervise cargo staff in 14 Chinese cities and to develop the cargo business in the PRC. During his employment with Cathay Pacific, Mr. Lee was seconded to Air China Cargo Company Limited in Beijing, a state-owned airline enterprise in the PRC, from March 2011 to July 2011 where he served as the assistant president of its commercial (sales and marketing) division. From July 2007 to July 2009, he was seconded to Hong Kong Dragon Airlines Ltd. in Shanghai, the PRC, where he served as a manager of marketing & sales in Eastern China. Mr. Lee graduated from the University of Hong Kong with a bachelor of business administration degree in accounting and finance in July 2001. In March 2007, Mr. Lee attended the SWIRE Management Programme organised by INSEAD Graduate Business School in Singapore.

Yeung Cheng

Mr. Cheng Yeung is General Manager - Medical Operations of the company. Since 4 November 2015. He is responsible for overseeing the medical related business operations of our Group. Mr. Cheng has more than 20 years of experience in the pharmaceutical industry having worked in various pharmaceutical companies including Allergan Hong Kong Limited, a healthcare company focused on developing and marketing pharmaceuticals products and medical devices, where he served as a senior sales and marketing manager. Mr. Cheng graduated from the Hong Kong Baptist University in December 1993 with a bachelor of science degree in applied biology. He completed a diploma course on smaller company management from the Chinese University of Hong Kong in February 1997, and obtained a master degree in business administration from Heriot-Watt University in November 2006.

Chun Pong Siu

Mr. Siu Chun Pong, Raymond is Company Secretary of the Company. He has been a practising solicitor of The High Court of Hong Kong since 2005. Mr. Siu has over 12 years of experience in corporate finance and regulatory compliance. Prior to setting up and running his own solicitors firm, he was a partner of F. Zimmern & Co., Solicitors and Notaries. Mr. Siu graduated from The University of Hong Kong with a Bachelor of Laws degree and University College London with a Master of Laws degree.

Kun Shing Ben Luk

Mr. Luk Kun Shing Ben re-designated as Non-Executive Director of the company. He joined our Group on 1 March 2010 and was appointed as our executive Director and chief information officer on 4 November 2015. He is responsible for overseeing information technology infrastructure of our Group. Mr. Luk has more than 5 years of experience in the aesthetic medical industry, and over 12 years of experience in the information technology industry. Prior to joining our Group, from January 2011 to February 2014, Mr. Luk served as a software engineer at Google (Hong Kong) Limited, a subsidiary of Google Inc., specialising in internet-related services and products. From December 2003 to December 2010, he was a software engineer at Google Inc., in Mountain View, California, the United States and involved in the implementation of Google Maps. Mr. Luk graduated from Cornell University with a bachelor of science degree in computer science in August 2000 and Stanford University with a master of science degree in computer science in June 2003.

Guowei Wang

Dr. Wang David Guowei serves as Non-Executive Director of the Company. Dr. Wang, has over 10 years of experience in the medical industry. Dr. Wang is the senior managing director of Asia at OrbiMed Advisors LLC, an investment fund with a focus on healthcare industry, where he has worked from August 2011. Dr. Wang was a director of Response Biomedical Corp. (Stock Code: RBM), a company listed on the Toronto Stock Exchange, from October 2011 to May 2015. From April 2006 to July 2011, he served as managing director at WI Harper Group, responsible for investment activities in life sciences and healthcare areas. From March 2010 to July 2012, he served on the board of directors of Edan instruments, Inc. (a company listed on the Shenzhen Stock Exchange, stock code: 300206), a provider of advanced electronic medical equipments where he also served on both the audit committee and strategic committee. Dr. Wang is now serving on the board of directors of Suzhou Medical System Technology Co., Ltd. (a company listed on the Shanghai Stock Exchange, stock code: 603990), serving on the boards of directors of Amoy Diagnostics Co., Ltd. (a company listed on the Shenzhen Stock Exchange, stock code: 300685), and serving on the boards of directors of AK Medical Holdings Limited (a company listed on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”), stock code: 1789). Dr. Wang received his doctorate in developmental biology from California Institute of Technology in June 1995. He received his bachelor degree in medicine from Beijing Medical University (currently known as Peking University Health Science Centre in July 1986.

Chi Hang Lam

Mr. Lam Chi Hang, Josekin is Non-Executive Independent Director of the Company. He has extensive knowledge and over 17 years of experience in business consultancy and financial industry. Prior to setting up and running his own business consultancy and real estate brokerage firms in 2009 and 2014 respectively, Mr. Lam was a consultant at Bain & Co, Inc , a management consulting company. Mr. Lam was the acting chief executive officer of Sanook.com, a subsidiary of Tecent Holdings Limited (“Tecent”), a company listed on the Main Board of the Stock Exchange (Stock Code: 700). Prior to joining the Group, Mr. Lam last held the position as a director of strategy department of Tecent. Mr. Lam graduated from Tufts University with a Bachelor of Arts degree in Quantitative Economics and International Relations in May 2001 and the University of Chicago Booth School of Business with a Master of Business Administration in June 2007.

Andrew Look

Mr. Look Andrew is Non-Executive Independent Director of the company. He has over 15 years of experience in equity investment analysis of Hong Kong and the PRC stock markets and in the banking, property development and fund management industries. Prior to joining our Group, Mr. Look has been the founder, chief investment officer and managing director of Look’s Asset Management Limited, an equity investment company incorporated in September 2009. From June 2000 to August 2008, he was the managing director and the head of Hong Kong research, strategy and product of UBS Securities Asia Limited, where he was responsible for producing thematic and quality market strategy reports for hedge fund and wealth management clients. Mr. Look has served as the independent non-executive director of Ka Shui International Holdings Limited, a company engaged in the manufacture and sale of zinc, magnesium and aluminium alloy die casting components, listed on the Main Board of the Stock Exchange (Stock Code: 0822) since December 2009, TCL Communication Technology Holdings Limited, a company engaged in the provision of mobile handsets in China, listed on the Main Board of the Stock Exchange (Stock Code: 2618) since September 2010, Man Sang Jewellery Holdings Limited, a company engaged in the purchasing, processing, designing, production and wholesale distribution of pearls and jewellery products, listed on the Main Board of the Stock Exchange (Stock Code: 1466) since October 2014, Hung Fook Tong Group Holdings Limited, a company engaged in the production and sales of Chinese herbal drinks and other drink products, listed on the Main Board of the Stock Exchange (Stock Code: 1446) since June 2014, and CITIC Resources Holdings Limited, a company engaged in the provision of strategic natural resources and key commodities, listed on the Main Board of the Stock Exchange (Stock Code: 1205) since September 2015. Mr. Look graduated from the University of Toronto with a bachelor of commerce degree in June 1986.

Ching Nam Ma

Mr. Ma Ching Nam is Non-Executive Independent Director of the company. Since 19 February 2016. Mr. Ma has been practising law for almost 35 years. He was admitted as a solicitor in England and Wales, Hong Kong, Australia and Singapore. He currently serves as senior partner of Hastings & Co, Solicitors & Notaries, a law firm in Hong Kong. Mr. Ma is also a Notary Public, China Appointed Attesting Officer and Civil Celebrant. He was the president of the Hong Kong Society of Notaries from 2007 to 2013. Mr. Ma currently serves as directors of Tai Sang Bank Limited, Heptacontinental group of companies, Chiu Yin Enterprises Limited, Ma Kam Ming Company Limited and Ma’s Enterprises Company Limited. He is also an independent non-executive director of Time Watch Investments Limited which was listed on the Main Board of the Stock Exchange (Stock Code: 2033). Mr. Ma has also been a director and Vice Chairman of Po Leung Kuk since 2009 and 2014 respectively. Mr. Ma is also a member of the Hospital Governing Committee of North District Hospital in Hong Kong, a member of the Standing Committee on Language Education and Research (SCOLAR) in Hong Kong, and a council member of Hong Kong St. John Ambulance. He has been appointed as a member of Political and Consultative Conference in Hunan Province, PRC. He was also one of the past Chairmen of St. Paul’s Co-educational College Alumni Association. Mr. Ma graduated from the University of Hull with a bachelor of science degree in economics with honours in 1977.

Basic Compensation

Name Fiscal Year Total

Chi Fai Tang

1,235,000

Gabriel Lee

1,538,650

Yeung Cheng

--

Chun Pong Siu

--

Kun Shing Ben Luk

168,000

Guowei Wang

--

Chi Hang Lam

--

Andrew Look

--

Ching Nam Ma

--
As Of  31 Mar 2015